Literature DB >> 29065796

Circadian hormone control in a human-on-a-chip: In vitro biology's ignored component?

Kevin J Cyr1,2, Omero M Avaldi1,2, John P Wikswo1,3,4,5.   

Abstract

Organs-on-Chips (OoCs) are poised to reshape dramatically the study of biology by replicating in vivo the function of individual and coupled human organs. Such microphysiological systems (MPS) have already recreated complex physiological responses necessary to simulate human organ function not evident in two-dimensional in vitro biological experiments. OoC researchers hope to streamline pharmaceutical development, accelerate toxicology studies, limit animal testing, and provide new insights beyond the capability of current biological models. However, to develop a physiologically accurate Human-on-a-Chip, i.e., an MPS homunculus that functions as an interconnected, whole-body, model organ system, one must couple individual OoCs with proper fluidic and metabolic scaling. This will enable the study of the effects of organ-organ interactions on the metabolism of drugs and toxins. Critical to these efforts will be the recapitulation of the complex physiological signals that regulate the endocrine, metabolic, and digestive systems. To date, with the exception of research focused on reproductive organs on chips, most OoC research ignores homuncular endocrine regulation, in particular the circadian rhythms that modulate the function of all organ systems. We outline the importance of cyclic endocrine regulation and the role that it may play in the development of MPS homunculi for the pharmacology, toxicology, and systems biology communities. Moreover, we discuss the critical end-organ hormone interactions that are most relevant for a typical coupled-OoC system, and the possible research applications of a missing endocrine system MicroFormulator (MES-µF) that could impose biological rhythms on in vitro models. By linking OoCs together through chemical messenger systems, advanced physiological phenomena relevant to pharmacokinetics and pharmacodynamics studies can be replicated. The concept of a MES-µF could be applied to other standard cell-culture systems such as well plates, thereby extending the concept of circadian hormonal regulation to much of in vitro biology. Impact statement Historically, cyclic endocrine modulation has been largely ignored within in vitro cell culture, in part because cultured cells typically have their media changed every day or two, precluding hourly adjustment of hormone concentrations to simulate circadian rhythms. As the Organ-on-Chip (OoC) community strives for greater physiological realism, the contribution of hormonal oscillations toward regulation of organ systems has been examined only in the context of reproductive organs, and circadian variation of the breadth of other hormones on most organs remains unaddressed. We illustrate the importance of cyclic endocrine modulation and the role that it plays within individual organ systems. The study of cyclic endocrine modulation within OoC systems will help advance OoC research to the point where it can reliably replicate in vitro key regulatory components of human physiology. This will help translate OoC work into pharmaceutical applications and connect the OoC community with the greater pharmacology and physiology communities.

Entities:  

Keywords:  diurnal rhythms; endocrine; microformulator; organs-on-chips; pharmacology; toxicology

Mesh:

Year:  2017        PMID: 29065796      PMCID: PMC5832251          DOI: 10.1177/1535370217732766

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  147 in total

Review 1.  The role of circadian timing system on drug metabolism and detoxification.

Authors:  Frédéric Gachon; Dmitri Firsov
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-12-31       Impact factor: 4.481

Review 2.  Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposure.

Authors:  Jong Hwan Sung; Balaji Srinivasan; Mandy Brigitte Esch; William T McLamb; Catia Bernabini; Michael L Shuler; James J Hickman
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-20

Review 3.  Metabolic effects of GH: a rationale for continued GH treatment of GH-deficient adults after cessation of linear growth.

Authors:  A Juul; J O Jørgensen; J S Christiansen; J Müller; N E Skakkeboek
Journal:  Horm Res       Date:  1995

4.  Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts.

Authors:  J D Veldhuis; A Iranmanesh; M L Johnson; G Lizarralde
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

5.  Diurnal variation in glucose tolerance: associated changes in plasma insulin, growth hormone, and non-esterified fatty acids.

Authors:  P Z Zimmet; J R Wall; R Rome; L Stimmler; R J Jarrett
Journal:  Br Med J       Date:  1974-03-16

6.  Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability.

Authors:  Christopher B Forsyth; Robin M Voigt; Maliha Shaikh; Yueming Tang; Arthur I Cederbaum; Fred W Turek; Ali Keshavarzian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-09       Impact factor: 4.052

7.  Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human.

Authors:  P Chao; T Maguire; E Novik; K-C Cheng; M L Yarmush
Journal:  Biochem Pharmacol       Date:  2009-05-20       Impact factor: 5.858

8.  The calcineurin-NFAT pathway controls activity-dependent circadian gene expression in slow skeletal muscle.

Authors:  Kenneth A Dyar; Stefano Ciciliot; Guidantonio Malagoli Tagliazucchi; Giorgia Pallafacchina; Jana Tothova; Carla Argentini; Lisa Agatea; Reimar Abraham; Miika Ahdesmäki; Mattia Forcato; Silvio Bicciato; Stefano Schiaffino; Bert Blaauw
Journal:  Mol Metab       Date:  2015-09-25       Impact factor: 7.422

9.  Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.

Authors:  J Fang; C Cai; Q Wang; P Lin; Z Zhao; F Cheng
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-03-14

Review 10.  Circadian regulation of metabolic homeostasis: causes and consequences.

Authors:  Graham R McGinnis; Martin E Young
Journal:  Nat Sci Sleep       Date:  2016-05-27
View more
  6 in total

1.  Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.

Authors:  David E Watson; Rosemarie Hunziker; John P Wikswo
Journal:  Exp Biol Med (Maywood)       Date:  2017-10

2.  A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models.

Authors:  Dharaminder Singh; Sudhir P Deosarkar; Elaine Cadogan; Vikki Flemington; Alysha Bray; Jingwen Zhang; Ronald S Reiserer; David K Schaffer; Gregory B Gerken; Clayton M Britt; Erik M Werner; Francis D Gibbons; Tomasz Kostrzewski; Christopher E Chambers; Emma J Davies; Antonio Ramos Montoya; Jacqueline H L Fok; David Hughes; Kristin Fabre; Matthew P Wagoner; John P Wikswo; Clay W Scott
Journal:  PLoS Biol       Date:  2022-05-26       Impact factor: 9.593

Review 3.  The Microbiome and the Gut-Liver-Brain Axis for Central Nervous System Clinical Pharmacology: Challenges in Specifying and Integrating In Vitro and In Silico Models.

Authors:  Kyle G Hawkins; Caleb Casolaro; Jacquelyn A Brown; David A Edwards; John P Wikswo
Journal:  Clin Pharmacol Ther       Date:  2020-05-29       Impact factor: 6.875

Review 4.  Critical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS).

Authors:  Mridu Malik; Yang Yang; Parinaz Fathi; Gretchen J Mahler; Mandy B Esch
Journal:  Front Cell Dev Biol       Date:  2021-09-09

Review 5.  Recent Advances in Chronotherapy Targeting Respiratory Diseases.

Authors:  Keshav Raj Paudel; Saurav Kumar Jha; Venkata Sita Rama Raju Allam; Parteek Prasher; Piyush Kumar Gupta; Rahul Bhattacharjee; Niraj Kumar Jha; Sukriti Vishwas; Sachin K Singh; Jesus Shrestha; Mohammad Imran; Nisha Panth; Dinesh Kumar Chellappan; Majid Ebrahimi Warkiani; Philip M Hansbro; Kamal Dua
Journal:  Pharmaceutics       Date:  2021-11-25       Impact factor: 6.321

6.  Circadian Effects of Drug Responses.

Authors:  Yaakov Nahmias; Ioannis P Androulakis
Journal:  Annu Rev Biomed Eng       Date:  2021-03-31       Impact factor: 9.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.